Literature DB >> 13394773

Epizootiology of vesicular stomatitis.

C A BRANDLY, R P HANSON.   

Abstract

Entities:  

Keywords:  FOOT AND MOUTH DISEASE

Mesh：

Year:  1957        PMID： 13394773      PMCID： PMC1551163          DOI： 10.2105/ajph.47.2.205

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  6 in total

1.  Experimental transmission of vesicular stomatitis virus by Diptera.

Authors:  D H FERRIS; R P HANSON; R J DICKE; R H ROBERTS
Journal:  J Infect Dis       Date:  1955 Mar-Apr       Impact factor: 5.226

2.  Potential insect vectors of vesicular stomatitis in Wisconsin.

Authors:  R H ROBERTS; R J DICKE; R P HANSON; D H FERRIS
Journal:  J Infect Dis       Date:  1956 Mar-Apr       Impact factor: 5.226

3.  Isolation of vesicular stomatitis virus from an infected laboratory worker.

Authors:  O N FELLOWES; G T DIMOPOULLOS; J J CALLIS
Journal:  Am J Vet Res       Date:  1955-10       Impact factor: 1.156

4.  Pathological changes of experimental vesicular stomatitis of swine.

Authors:  T L CHOW; S H MCNUTT
Journal:  Am J Vet Res       Date:  1953-07       Impact factor: 1.156

5.  The natural history of vesicular stomatitis.

Authors:  R P HANSON
Journal:  Bacteriol Rev       Date:  1952-09

6.  Human infection with the virus of vesicular stomatitis.

Authors:  R P HANSON; A F RASMUSSEN; C A BRANDLY; J W BROWN
Journal:  J Lab Clin Med       Date:  1950-11
  6 in total
  17 in total

1.  Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Authors:  Selidji T Agnandji; Angela Huttner; Madeleine E Zinser; Patricia Njuguna; Christine Dahlke; José F Fernandes; Sabine Yerly; Julie-Anne Dayer; Verena Kraehling; Rahel Kasonta; Akim A Adegnika; Marcus Altfeld; Floriane Auderset; Emmanuel B Bache; Nadine Biedenkopf; Saskia Borregaard; Jessica S Brosnahan; Rebekah Burrow; Christophe Combescure; Jules Desmeules; Markus Eickmann; Sarah K Fehling; Axel Finckh; Ana Rita Goncalves; Martin P Grobusch; Jay Hooper; Alen Jambrecina; Anita L Kabwende; Gürkan Kaya; Domtila Kimani; Bertrand Lell; Barbara Lemaître; Ansgar W Lohse; Marguerite Massinga-Loembe; Alain Matthey; Benjamin Mordmüller; Anne Nolting; Caroline Ogwang; Michael Ramharter; Jonas Schmidt-Chanasit; Stefan Schmiedel; Peter Silvera; Felix R Stahl; Henry M Staines; Thomas Strecker; Hans C Stubbe; Benjamin Tsofa; Sherif Zaki; Patricia Fast; Vasee Moorthy; Laurent Kaiser; Sanjeev Krishna; Stephan Becker; Marie-Paule Kieny; Philip Bejon; Peter G Kremsner; Marylyn M Addo; Claire-Anne Siegrist
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

2.  A Review of Current Knowledge of the Vesicular Diseases.

Authors:  M S Shahan
Journal:  Can Vet J       Date:  1960-10       Impact factor: 1.008

Review 3.  Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.

Authors:  Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 4.  From bench to almost bedside: the long road to a licensed Ebola virus vaccine.

Authors:  Gary Wong; Emelissa J Mendoza; Francis A Plummer; George F Gao; Gary P Kobinger; Xiangguo Qiu
Journal:  Expert Opin Biol Ther       Date:  2017-11-17       Impact factor: 4.388

5.  Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.

Authors:  A Roberts; E Kretzschmar; A S Perkins; J Forman; R Price; L Buonocore; Y Kawaoka; J K Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  Attenuated vesicular stomatitis viruses as vaccine vectors.

Authors:  A Roberts; L Buonocore; R Price; J Forman; J K Rose
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.

Authors:  N F Rose; A Roberts; L Buonocore; J K Rose
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Pre-clinical development of a vaccine against Lassa fever.

Authors:  L Banadyga; D R Stein; X Qiu; D Safronetz
Journal:  Can Commun Dis Rep       Date:  2018-06-07

10.  In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Authors:  J Erik Johnson; John W Coleman; Narender K Kalyan; Priscilla Calderon; Kevin J Wright; Jennifer Obregon; Eleanor Ogin-Wilson; Robert J Natuk; David K Clarke; Stephen A Udem; David Cooper; R Michael Hendry
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.